# T-Cell PET Imaging With [18F]F-AraG in Lung Cancer

> **NCT03311672** · PHASE2 · WITHDRAWN · sponsor: **University of California, San Francisco**

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** [18F]F-Ara-G
- **DRUG:** Pembrolizumab
- **RADIATION:** PET/CT scan

## Key facts

- **NCT ID:** NCT03311672
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-11-26
- **Primary completion:** 2019-10-15
- **Final completion:** 2019-10-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Low Accrual
- **Last updated:** 2019-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03311672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03311672, "T-Cell PET Imaging With [18F]F-AraG in Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03311672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*